Pediatric Conditions of the Respiratory System

Subtopic:

Pneumonia

Pneumonia involves inflammation of the lung tissue itself (parenchyma). This condition is typically identified by the presence of a cough, along with an increased rate of breathing (tachypnea) and difficulty breathing (dyspnea). The cause is usually the introduction of various microorganisms into the lungs. These can include bacteria, mycobacteria (like the bacteria that causes tuberculosis), fungi, and viruses. These infectious agents can reach the lungs either through breathing them in directly from the air or by traveling through the bloodstream from another part of the body.

Causes of Pneumonia

Pneumonia can be triggered by a range of infectious agents.

Bacterial: Common bacterial causes include Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Moraxella catarrhalis, and Legionella species.

Viral: Various viruses can lead to pneumonia, such as respiratory syncytial viruses (RSV), Influenza A and B viruses, adenoviruses, and parainfluenza viruses.

Fungal: Infections caused by fungi can also result in pneumonia. Examples include Histoplasma capsulatum, Coccidioides immitis, Pneumocystis jirovecii, or Cryptococcus neoformans.

Classifications of Pneumonia.

Pneumonia can be categorized based on several factors.

Classification is according to:

  1. Etiology

  2. Anatomical

  3. Duration

  4. Clinical grounds

1. Etiologic classification

This classification is based on the cause of the pneumonia.

  1. Infective pneumonia: This category encompasses pneumonia caused by infectious agents.

    • Viral pneumonia: Pneumonia caused by viruses, for example, Influenza A virus.

    • Bacterial pneumonia: Pneumonia caused by bacteria, such as Streptococcus pneumoniae.

    • Fungal pneumonia: Pneumonia caused by fungal infections.

    • Tuberculous pneumonia: Pneumonia caused by Mycobacterium tuberculosis (M.TB).

  2. Non Infective pneumonia: This type of pneumonia is not caused by infectious agents. Possible causes include:

    • Toxins: Exposure to harmful substances can irritate and inflame the lungs.

    • Chemicals: Inhalation of certain chemicals, such as paraffin or vomitus (aspiration pneumonia), can lead to lung inflammation.

    • Radiotherapy: Radiation therapy to the chest area can sometimes damage lung tissue and cause pneumonia.

    • Allergic mechanisms: In some cases, an exaggerated immune response to allergens can trigger lung inflammation resembling pneumonia.

2. Anatomical

This classification refers to the area of the lung affected by the inflammation.

  1. Lobar pneumonia: The inflammation is primarily confined to one or more lobes of the lung. Each lung is divided into sections called lobes.

2. Bronchopneumonia – In this type, the pneumonia involves inflammation of both the larger airways (bronchi) and the smaller airways (bronchioles). The inflammation is generally more widespread (diffuse) and primarily affects smaller functional units of the lung called lobules.

3. Interstitial pneumonia – Here, the inflammation mainly affects the supporting tissue of the lung, known as the interstitium. This tissue surrounds the air sacs and blood vessels of the lungs.

3. Duration

This classification is based on how long the pneumonia lasts.

  1. Acute pneumonia: This type of pneumonia has a shorter course, typically lasting only a few days and not extending beyond two weeks.

  2. Chronic Pneumonia: This form of pneumonia persists for a longer period.

    • It lasts for more than two weeks.

    • It is more frequently seen in patients with weakened immune systems (Immune Suppressed patients).

    • Tuberculosis (TB) is a common cause of chronic pneumonia.

4. Clinical Grounds

This classification categorizes pneumonia based on the setting in which it was acquired or specific patient populations affected.

  1. Community-acquired pneumonia (CAP):

    • CAP is diagnosed when a person develops pneumonia in their everyday environment (community setting) or within the first 48 hours after being admitted to a hospital. This timeframe suggests the infection was present before hospitalization.

    • Common causative agents include Streptococcus pneumoniae, Haemophilus influenzae, Legionella species, and Pseudomonas aeruginosa.

    • In individuals younger than 60 years old, pneumonia is the most frequent cause of CAP.

    • Viruses are the most common cause of pneumonia in babies and young children.

  2. Hospital acquired (Nosocomial pneumonia):

    • Hospital Acquired Pneumonia (HAP), also known as nosocomial pneumonia, is defined as pneumonia that develops more than 48 hours after a patient is admitted to a hospital. This time frame indicates the infection was likely acquired within the hospital setting. Patients must not have shown signs of infection upon admission to be classified as having HAP.

    • HAP is considered a serious healthcare-associated infection. It is the most harmful type of nosocomial infection and is a leading cause of death in patients who develop such infections.

    • Common microorganisms responsible for HAP include Enterobacter species, Escherichia coli, influenza viruses, Klebsiella species, Proteus species, Serratia marcescens, Staphylococcus aureus, and Streptococcus pneumoniae.

  3. Aspiration pneumonia:

    • Aspiration pneumonia occurs when substances from the upper airways, either produced by the body (endogenous) or from outside the body (exogenous), enter the lower airways and lungs.

    • The most frequent form of aspiration pneumonia is a bacterial infection resulting from inhaling bacteria that normally live in the upper respiratory tract.

    • Aspiration pneumonia can occur both in community settings and within hospitals.

    • Common pathogens involved are Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus.

  4. Pneumonia in immunocompromised patients:

    • This category includes specific types of pneumonia that are more common or severe in individuals with weakened immune systems. Examples include Pneumocystis pneumonia, various fungal pneumonias, and pneumonia caused by Mycobacterium tuberculosis.

    • Patients with compromised immunity are more susceptible to developing pneumonia from organisms that typically do not cause disease in healthy individuals (organisms of low virulence).

    • It is important to note that pneumonia in immunocompromised patients can also be caused by the same organisms seen in HAP and CAP.

  5. Primary or secondary pneumonia

    • 1. Primary pneumonia: This type of pneumonia develops in previously healthy individuals living in the community. It is often lobar pneumonia caused by Streptococcus pneumoniae.

    • 2. Secondary pneumonia: This type of pneumonia develops as a consequence of a pre-existing condition or situation. It can occur:

      • After a previous respiratory illness.

      • In individuals with weakened immune systems, such as those with AIDS.

      • Following a surgical operation, making it a risk for post-operative patients.

Pathophysiology of Pneumonia

This describes the sequence of biological events that occur in the body during the development of pneumonia.

When infectious agents reach the alveoli (the tiny air sacs in the lungs), they attach to the walls of the bronchi and bronchioles (the airways).

These agents then multiply outside of the cells (extracellularly), triggering an inflammatory response. This inflammation leads to the leakage of fluid and inflammatory cells (exudates) into the air spaces of the alveoli.

White blood cells (WBCs), the body’s defense cells, migrate to the alveoli to fight the infection. The alveoli become thickened and solid (consolidation) as they fill with this exudate.

Due to the inflammation, the affected areas of the lung are not adequately ventilated, meaning air cannot flow in and out properly. This is due to increased secretions and swelling (edema) in the airways.

This leads to a partial blockage (occlusion) of the alveoli and bronchi, causing a reduction in the amount of oxygen within the alveoli.

As a result, venous blood returning from the affected areas to the heart does not get fully oxygenated in the lungs.

This results in a lower than normal level of oxygen in the arterial blood (arterial hypoxemia). If the interference with gas exchange is severe enough, it can even lead to death.

Clinical Features of Pneumonia

These are the signs and symptoms that a person with pneumonia might experience.

  • Fever with chills (Temperature 38-39°C): An elevated body temperature is a common sign of infection.

  • Cough (may be absent in neonates and infants) with sputum production in older children: A cough, which may produce phlegm or mucus in older children, is a typical symptom. However, it may be absent in very young infants.

  • Fast breathing (Tachypnea): An increased respiratory rate is a key indicator that the body is trying to compensate for reduced oxygen intake.

  • Nasal flaring: (with inspiration, the side of the nostrils flares outwards): The widening of the nostrils during inhalation is a sign of increased effort to breathe.

  • Chest indrawing: (it is inward movement of the lower chest wall when the child breathes in): This occurs when the muscles between the ribs are pulled inward during inhalation, indicating significant difficulty breathing.

  • Altered consciousness: Changes in alertness or awareness can occur due to reduced oxygen levels in the brain.

  • Irritability: Increased fussiness or agitation, especially in infants and young children.

  • Shortness of breath: A subjective feeling of difficulty getting enough air.

  • Grunting respirations: A short, guttural sound made during exhalation, indicating an attempt to keep the alveoli open.

  • Chest in-drawing: (Repeated for emphasis).

  • Stridor: A high-pitched, whistling sound during breathing, often indicating an upper airway obstruction, but can be present in some cases of pneumonia.

  • Wheezing: A whistling or musical sound during breathing, indicating narrowed airways.

  • Crackles: Also known as rales, these are popping or bubbling sounds heard during inhalation, indicating fluid in the small airways.

  • Decreased breath sounds: When listening with a stethoscope, the intensity of breath sounds may be reduced over the affected area of the lung.

Diagnosis and Investigations

These are the methods used to confirm a diagnosis of pneumonia.

History taking. The process of diagnosing pneumonia often starts with gathering information about the patient’s medical history, paying particular attention to any recent respiratory tract infections.

Physical examination. A key part of the diagnostic process involves a physical examination. Specifically, the healthcare provider will assess the patient’s breathing rate (number of breaths per minute) and listen to their breath sounds using a stethoscope.

Chest x-ray. This imaging technique is crucial for confirming the diagnosis and assessing the extent of the pneumonia. It helps to identify the structural distribution of the infection, such as whether it is lobar (confined to a lobe) or bronchial (involving the airways). The chest x-ray can also reveal other features, such as multiple abscesses or infiltrates (seen more often with staphylococcus infections), empyema (pus in the space between the lung and the chest wall, also associated with staphylococcus), scattered or localized infiltration (common in bacterial pneumonia), or diffuse/extensive nodular infiltrates (more frequently seen in viral pneumonia). Interestingly, in cases of mycoplasma pneumonia, the chest x-ray may sometimes appear clear despite the presence of infection.

Arterial Blood Gas/pulse oximetry. These tests measure the oxygen and carbon dioxide levels in the blood. Results can be abnormal depending on how much of the lung is affected and if there are any pre-existing lung problems. Pulse oximetry provides a non-invasive way to estimate blood oxygen saturation.

Gramstain/cultures. These laboratory tests help identify the specific organism causing the pneumonia. Samples like sputum, fluid from a lung abscess or pleural space, or fluid from a tracheal wash are collected. Lung biopsies and blood cultures might also be performed. It’s possible to have more than one type of organism present. Common bacteria include Diplococcus pneumoniae, Staphylococcus aureus, alpha-hemolytic streptococcus, and Haemophilus influenzae. Cytomegalovirus (CMV) can also be a cause. Note that sputum cultures might not always identify all the organisms causing the infection. Blood cultures may temporarily show bacteria in the bloodstream.

CBC. A complete blood count measures different types of blood cells. Often, there’s an increase in white blood cells (leukocytosis) indicating infection. However, a low white blood cell count can occur in viral infections, in people with weakened immune systems like those with AIDS, or in severe bacterial pneumonia. The erythrocyte sedimentation rate (ESR), a marker of inflammation, is usually elevated.

Serologic studies, e.g., viral or Legionella titers, cold agglutinins. These blood tests help identify specific antibodies or substances related to particular infections, aiding in the diagnosis of specific organisms like viruses or Legionella. Cold agglutinins are antibodies that can clump red blood cells at low temperatures and are associated with certain infections like Mycoplasma pneumoniae.

Pulmonary function studies. These tests assess how well the lungs are working. Lung volumes might be reduced due to congestion and collapsed air sacs (alveolar collapse). Airway pressure might be increased, and the lungs might be less flexible (decreased compliance). Shunting, where blood passes through the lungs without getting oxygenated, may be present, leading to low blood oxygen (hypoxemia).

Electrolytes. Blood tests may show low levels of sodium and chloride, especially in severe cases.

Bilirubin. Bilirubin, a yellow pigment produced when red blood cells break down, might be increased in some cases.

Management of Pneumonia

Even though viruses are a common cause of pneumonia in young children, it’s essential to treat pneumonia as potentially bacterial and start antibiotic treatment.

Prompt treatment with appropriate antibiotics is crucial. For children without serious pneumonia, amoxicillin is usually the first choice. For infants under 2 months with severe pneumonia, the initial treatment is often a combination of ampicillin (given intravenously at a dose of 150-200mg/kg per day, divided into multiple doses) plus gentamicin (given intravenously at a dose of 5-6 mg/kg per day) for 10 days. If penicillin isn’t available, cefotaxime can be used as an alternative. If the child’s condition doesn’t improve, cloxacillin may be added.

For older children between 2 months and 5 years, ceftriaxone is a first-line treatment option, or ampicillin combined with gentamicin can be used.

Fever is managed with paracetamol. Tepid sponging (using lukewarm water to cool the skin) can be done when necessary.

Positioning the patient in a semi-sitting up position with their head elevated helps to improve breathing.

In newborns, it’s important to clear the airway, which may involve nasal irrigation using a sodium chloride 0.9% solution.

Careful monitoring for increased respiratory distress is essential to detect any worsening of the condition.

If the patient is unable to clear their airway effectively, assisting them to cough or using suction to remove secretions may be necessary.

Bronchodilators may be administered to help open up the airways.

Oxygen therapy is needed when cyanosis (bluish discoloration due to low oxygen) is present.

Fluid management is important. Encourage adequate rehydration. For children with severe breathing difficulties, an intravenous (IV) line may be started to give fluids, typically at 70% of their normal maintenance fluid requirements. Oral fluids should be resumed as soon as the child is able to tolerate them.

Ensure well-balanced nutrition, which may be provided via a nasogastric tube (NGT) if the child has difficulty eating. If there are no severe breathing problems, breastfeeding should continue on demand.

Regular observations of respiratory rate, temperature, and pulse rate are essential to monitor the patient’s progress.

Maintaining good hygiene is important to prevent further infections.

Keep the patient warm and dry. Change the patient’s position as needed.

Physiotherapy, specifically chest exercises, can help to clear secretions from the lungs.

Complications of Pneumonia

These are potential negative outcomes that can occur as a result of pneumonia.

  • Bacteria in blood stream (bacteremia)/sepsis: The infection can spread from the lungs into the bloodstream, leading to bacteremia or a more severe systemic infection called sepsis.

  • Lung abscesses: A collection of pus can form within the lung tissue.

  • Empyema: Pus can accumulate in the space between the lung and the chest wall (pleural space).

  • Pleural effusion: Fluid can build up in the pleural space.

  • Obstructive airway secretion: Thick mucus can block the airways, making it difficult to breathe.

  • Shock and respiratory failure: Severe pneumonia can lead to dangerously low blood pressure (shock) and the inability of the lungs to provide enough oxygen (respiratory failure).

  • Necrotizing pneumonia: A severe form of pneumonia where lung tissue dies.

  • Chronic lung disease: In some cases, pneumonia can cause long-term damage to the lungs.

Nursing Diagnosis

These are clinical judgments about the patient’s health conditions and needs related to pneumonia.

  1. Impaired tissue oxygenation related to inflammatory process in airway passages evidenced by cyanosis: The patient has reduced oxygen in their tissues due to airway inflammation, as indicated by bluish skin discoloration.

  2. Extreme anxiety related to the frequent life threatening asthmatic attacks evidenced by patient asking many questions: This diagnosis seems to be carried over from the asthma notes and is not directly relevant to pneumonia. It should likely be adjusted to reflect anxiety related to the pneumonia and breathing difficulties.

  3. Impaired breathing patterns related to inflammatory process in the lungs evidenced by use of accessory muscles/wheezing: The patient’s breathing is abnormal due to lung inflammation, as shown by the use of extra muscles to breathe and a whistling sound during breathing.

  4. Altered body temperature related to inflammatory process in the lungs evidenced by a high thermometer reading: The patient has a fever due to the inflammatory process in their lungs.

  5. Ineffective airway clearance related to copious tracheobronchial secretions: The patient is having trouble clearing mucus from their airways.

  6. Risk for deficient fluid volume related to fever and a rapid respiratory rate: The patient is at risk of dehydration due to fever and increased breathing rate.